2021
Diversity Inclusion in United States Opioid Pharmacological Treatment Trials: A Systematic Review
Nalven T, Spillane N, Schick M, Weyandt L. Diversity Inclusion in United States Opioid Pharmacological Treatment Trials: A Systematic Review. Experimental And Clinical Psychopharmacology 2021, 29: 524-538. PMID: 34242040, PMCID: PMC8511246, DOI: 10.1037/pha0000510.Peer-Reviewed Original ResearchConceptsOpioid use disorderPharmacological treatmentPharmacological treatment trialsTreatment trialsRandomized controlled trialsLack of subgroup analysesDiverse sampleMultiracial individualsNative Hawaiian/Other Pacific IslanderAmerican Indian/Alaska Native (AI/ANMedication typeSystematic reviewPharmacological careMarginalized backgroundsRandomized clinical trialsPreferred Reporting ItemsBlack individualsOpioidSex/genderSES indicatorsNaltrexoneSubgroup analysisClinical trialsReporting ItemsIncreased risk
2020
A Call to Action: A Systematic Review Examining the Failure to Include Females and Members of Minoritized Racial/Ethnic Groups in Clinical Trials of Pharmacological Treatments for Alcohol Use Disorder
Schick M, Spillane N, Hostetler K. A Call to Action: A Systematic Review Examining the Failure to Include Females and Members of Minoritized Racial/Ethnic Groups in Clinical Trials of Pharmacological Treatments for Alcohol Use Disorder. Alcohol Clinical And Experimental Research 2020, 44: 1933-1951. PMID: 32997374, DOI: 10.1111/acer.14440.Peer-Reviewed Original ResearchConceptsAlcohol use disorderClinical trials of pharmacological treatmentsMinoritized racial/ethnic groupsUse disorderTrials of pharmacological treatmentsPharmacological treatmentRandomized clinical trials of pharmacologic treatmentRacial/ethnic groupsRacial/ethnic breakdownSignificant public health concernSystematic reviewMedication typeDisordersPublished randomized clinical trialsTreatment outcomesStudy limitationsHighest prevalence estimatesPreferred Reporting ItemsAlcoholPublic health concernRacial/ethnic characteristicsReporting ItemsSubgroup analysisPrevalence estimatesClinical trials